HIV-1 Nef protein in the nucleus influences adipogenesis as well as viral transcription through the peroxisome proliferator-activated receptors

AIDS

Volumn 18, Issue 2, 2004, Pages 189-198

  Otake, Kaori ^a   Omoto, Shinya ^b   Yamamoto, Takuya ^b   Okuyama, Harumi ^b   Okada, Hidechika ^c   Okada, Noriko ^c   Kawai, Masahiro ^c   Saksena, Nitin K ^d   Fujii, Yoichi R ^b  

^a NAGOYA UNIVERSITY HOSPITAL   (Japan)

^b NAGOYA CITY UNIVERSITY   (Japan)

^c NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^d WESTMEAD HOSPITAL   (Australia)

Author keywords

Fatty acids; HIV 1; Lipids; Long terminal repeats; Nef; Nutrition; Peroxisome proliferator activated receptors

Indexed keywords

FATTY ACID; NEF PROTEIN; NUCLEAR PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CELL LEVEL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LIPOGENESIS; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MICROARRAY; RECEPTOR UPREGULATION; REPORTER GENE; T LYMPHOCYTE; VIRUS CELL INTERACTION; VIRUS TRANSCRIPTION;

ADIPOSE TISSUE; CELL DIVISION; CELL LINE; CELL NUCLEUS; FATTY ACIDS; GENE PRODUCTS, NEF; HIV-1; HUMANS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; VIRUS REPLICATION;

EID: 1342289537     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200401230-00007     Document Type: Article

References (30)

1. Svoboda J, Hejinar J, Geryk J, Elleder D, Vernerova Z. Retroviruses in foreign species and the problem of provirus silencing. Gene 2000, 261:181-188.
2. Safrin S, Grunfeld C. Fat distribution and metabolic changes in patients with HIV infection. AIDS 1999, 13:2493-2505.
3. Lenhard JM, Croom DK, Weiel JE, Winegar DA. HIV protease inhibitors stimulate hepatic triglyceride synthesis. Arterioscler Thromb Biol 2000, 20:2625-2629.
4. Smith KJ, Skelton HC. Peroxisomal proliferator activity legand therapy for HIV lipodiestrophy. Clin Exp Dermatol 2001, 26:155-161.
5. Hayes MM, Lane BR, King SR, Markovitz DM, Coffey MJ. Peroxisome proliferator-activated receptor gamma agonists inhibit HIV-1 replication in macrophages by transcriptional and post-transcriptional effects. J Biol Chem 2002, 277:16913-16919.
6. Deacon NJ, Tsykin A, Solomon A, Smith K, Lundford-Menting M, Hooker DJ, et al. Genomic structure of an attenuated quasi-species of HIV-1 from a blood transfusion donor and recipients. Science 1995, 27:988-991.
7. Learmont JC, Geczy AF, Mills J, Ashton LJ, Raynes-Greenow CH, Garsia RJ, et al. Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1 - A report from the Sydney Blood Bank Cohort. N Engl J Med 1999, 340:1715-1722.
8. Beer B, Baier M, Megede JZ, Norley S, Kurth R. Vaccine effect using a live attenuated nef-deficient simian immunodeficiency virus of African green monkeys in the absence of detectable vaccine virus replication in vivo. Proc Natl Acad Sci USA 1998, 94:4062-4067.
9. Sawai ET, Hamza MS, Ye M, Shaw KE, Luciw PA. Pathogenic conversion of live-attenuated SIV vaccines is associated with expression of truncated nef. J Virol 2000, 74:2038-2045.
10. Jamieson BD, Aldovandi GM, Planelles V, Jowett JBM, Gao L, Bloch LM, et al. Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity. J Virol 1994, 6:3478-3485.
11. Simmons A, Aluvihare V, McMichael A. Nef triggers a transcriptional program in T cells imitating single-signal T cell activation and inducing HIV virulence mediators. Immunity 2001, 14:763-777.
12. Shaheduzzaman S, Krishnan V, Petrovic A, Bittner M, Meltzer P, Trent J, et al. Effects of HIV-1 Nef on cellular gene expression profiles. J Biomed Sci 2002, 9:82-96.
13. + T cells. J Immunol 1994, 153:5826-5837.
14. Shockett P, Difilippantonio M, Hellman N, Schatz D. A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice. Proc Natl Acad Sci USA 1995, 92:6522-6526.
15. Yamamoto T, Omoto S, Mizuguchi M, Mizukami H, Okuyama H, Okada N, et al. Double-stranded nef RNA interferes with human immunodeficiency virus type 1 replication. Microbiol Immunol 2002, 46:809-817.
16. Fang J-Y, Mikovits JA, Bagni R, Petrow-Sadowski CL, Ruscetti FW. Infection of lymphoid cells by integration-defective human immunodeficiency virus type 1 increases de novo methylation. J Virol 2001, 75:9753-9761.
17. Otake K, Ohta M, Minowada J, Hatama S, Takahashi A, Ikemoto A, et al. Extracellular Nef of HIV-1 can target CD4 memory T population. AIDS 2000, 14:1662-1664.
18. Quaranta MG, Camponeschi B, Straface E, Malorini W, Viora M. Induction of interleukin-15 production by HIV-1 Nef protein: a role in the proliferation of uninfected cells. Exp Cell Res 1999, 250:112-121.
19. Murti KG, Brown PS, Ratner L, Garcia V. Highly localized tracks of human immunodeficiency virus type 1 Nef in the nucleus of cells of a human CD4+ T-cell line. Proc Natl Acad Sci USA 1993, 90:11895-11899.
20. Ranki A, Lagerstedt A, Ovod V, Aavik E, Krohn KJ. Expression kinetics and subcellular localization of HIV-1 regulatory proteins Nef, Tat and Rev in acutely and chronically infected lymphoid cell lines. Arch Virol 1994, 139:365-378.
21. Orchard K, Perkins N, Chapman C, Harris J, Emery V, Goodwin G, et al. A novel T-cell protein which recognizes a palindromic sequence in the negative regulatory element of the human immunodeficiency virus long terminal repeat. J Virol 1990, 64:3234-3239.
22. Kersten S, Desvergne B, Wahli W. Roles of PPARs in health and disease. Nature 2000, 405:421-424.
23. Chinetti G, Griglio S, Antonucci M, Torra I, Delerive P, Majd Z, et al. Activation of proliferator-activated receptors α and γ induces apoptosis of human monocyte-derived macrophages. J Biol Chem 1998, 273:25573-25580.
24. Murphy KM, Sweet MJ, Ross IL, Hume DA. Effects of the tat and nef gene products of human immunodeficiency virus type 1 (HIV-1) on transcription controlled by the HIV-1 long terminal repeat and on cell growth in macrophages. J Virol 1993, 67:6956-6964.
25. Ilyinskii PO, Desrosiers RC. Efficient transcription and replication of simian immunodeficiency virus in the absence of NF-kappaB and Sp1 binding elements. J Virol 1996, 70:3118-3126.
26. Barroso I, Gurnell M, Crowley VEF, Agostini M, Schwabe JW, Soos MA, et al. Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 1999, 402:880-883.
27. Duval C, Chinetti G, Trottein F, Fruchart J, Staels B. The role of PPARs in atherosclerosis. Trends Mol Med 2002, 8:422-425.
28. Hanna Z, Kay DG, Cool M, Jothy S, Rebai N, Jolicoeur P. Transgenic mice expressing human immunodeficiency virus type 1 in immune cells develop a severe AIDS-like disease. J Virol 1998, 72:121-132.
29. Hanna Z, Kay DG, Rebai N, Guimond A, Jothy S, Jolicoeur P. Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell 1998, 95:163-175.
30. Cohen GB, Rangan VS, Chen BJ, Smith S, Baltimore D. The human thioesterase II protein binds to a site on HIV-1 Nef critical for CD4 down-regulation. J Biol Chem 2000, 275:23097-23105.